2042-0080

Parkinson s Disease

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 272 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact272 DOIs
2

Add abstracts to 36 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact36 DOIs
3

Deposit reference lists for 18 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact18 DOIs

DOIs for this ISSN

Showing the top 5 of 899 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Parkinson’s Disease: New Insights into Pathophysiology and R… (10.1155/2016/3121727)
Abstract References
55.70 12
2 Inflammation and Parkinson's Disease (10.4061/2011/729054)
Abstract References ORCID
52.42 4
3 Dopamine Oxidation and Autophagy (10.1155/2012/920953)
ORCID
50.22 101
4 Progression of Voice and Speech Impairment in the Course of… (10.1155/2013/389195)
ORCID
49.89 98
5 LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Sp… (10.1155/2012/391946)
ORCID
49.44 94
6 Parkinson's Disease and Systemic Inflammation (10.4061/2011/436813)
ORCID
47.98 82
7 High-Level Language Production in Parkinson's Disease: A Rev… (10.4061/2011/238956)
ORCID
47.02 75
8 Lipopolysaccharide Animal Models for Parkinson's Disease (10.4061/2011/327089)
ORCID
47.02 75
9 Walking with Music Is a Safe and Viable Tool for Gait Traini… (10.4061/2010/483530)
ORCID
46.43 71
10 The Nrf2/ARE Pathway: A Promising Target to Counteract Mitoc… (10.4061/2011/314082)
ORCID
46.13 69
11 MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Se… (10.1155/2015/219149)
ORCID
45.65 66
12 Differential Effects of Dopaminergic Therapies on Dorsal and… (10.4061/2011/572743)
ORCID
45.32 64
13 Olfactory Loss in Parkinson's Disease (10.4061/2011/450939)
ORCID
45.15 63
14 Mitochondrial Dysfunction in Parkinson's Disease (10.4061/2011/716871)
ORCID
44.98 62
15 Comparing the Mini-BESTest with the Berg Balance Scale to Ev… (10.1155/2012/375419)
ORCID
43.90 56
16 Effects of Various Flavonoids on the<mml:math xmlns:mml="htt… (10.4061/2010/650794)
ORCID
43.90 56
17 Limitations of Animal Models of Parkinson's Disease (10.4061/2011/658083)
ORCID
43.70 55
18 Acoustic Analysis of PD Speech (10.4061/2011/435232)
ORCID
42.69 50
19 Drosophila Models of Parkinson's Disease: Discovering Releva… (10.4061/2011/520640)
ORCID
42.69 50
20 Mitochondrial Contribution to Parkinson's Disease Pathogenes… (10.4061/2011/159160)
ORCID
42.47 49
21 Transcriptional Factor NF-<mml:math xmlns:mml="http://www.w3… (10.4061/2011/216298)
ORCID
42.03 47
22 Risk of Falls in Parkinson’s Disease: A Cross-Sectional Stud… (10.1155/2012/362572)
ORCID
41.80 46
23 Lipid-Mediated Oxidative Stress and Inflammation in the Path… (10.4061/2011/247467)
ORCID
41.80 46
24 Nonmotor Symptoms in Parkinson’s Disease in 2012: Relevant C… (10.1155/2012/198316)
ORCID
41.33 44
25 Mitochondrial Dysfunction and<mml:math xmlns:mml="http://www… (10.1155/2015/108029)
ORCID
41.33 44
26 Neurobiology of Depression and Anxiety in Parkinson's Diseas… (10.4061/2011/143547)
ORCID
41.33 44
27 Is Freezing of Gait in Parkinson's Disease a Result of Multi… (10.1155/2012/459321)
ORCID
40.84 42
28 Periodontal Health and Caries Prevalence Evaluation in Patie… (10.1155/2012/541908)
ORCID
40.32 40
29 An Expert Diagnosis System for Parkinson Disease Based on Ge… (10.1155/2016/5264743)
ORCID
40.05 39
30 Perception of Speech by Individuals with Parkinson's Disease… (10.4061/2011/389767)
ORCID
39.49 37
31 Impact of Anxiety on Quality of Life in Parkinson's Disease (10.1155/2012/640707)
ORCID
39.21 36
32 Treatment of Advanced Parkinson's Disease (10.4061/2010/480260)
ORCID
39.21 36
33 The Endotoxin-Induced Neuroinflammation Model of Parkinson's… (10.4061/2011/487450)
ORCID
39.21 36
34 Methamphetamine and Parkinson's Disease (10.1155/2013/308052)
ORCID
38.60 34
35 Interleukin-6 May Contribute to Mortality in Parkinson’s Dis… (10.1155/2015/898192)
ORCID
38.60 34
36 The Involvement of Neuroinflammation and Kynurenine Pathway… (10.4061/2011/716859)
ORCID
38.60 34
37 The Parkinsonian Gait Spatiotemporal Parameters Quantified b… (10.1155/2015/390512)
ORCID
38.29 33
38 Genetic Profile, Environmental Exposure, and Their Interacti… (10.1155/2016/6465793)
ORCID
37.96 32
39 Dual-Task Interference: The Effects of Verbal Cognitive Task… (10.4061/2010/696492)
ORCID
37.96 32
40 Accuracy of Fall Prediction in Parkinson Disease: Six-Month… (10.1155/2012/237673)
ORCID
37.63 31
41 Camptocormia in Parkinson's Disease (10.4061/2010/267640)
ORCID
37.63 31
42 Neuropsychiatric Symptoms in Parkinson's Disease with Mild C… (10.1155/2012/308097)
ORCID
37.28 30
43 Effect of Exercise on Motor and Nonmotor Symptoms of Parkins… (10.1155/2015/586378)
ORCID
37.28 30
44 Salivary Acetylcholinesterase Activity Is Increased in Parki… (10.1155/2015/156479)
ORCID
36.93 29
45 Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson… (10.1155/2016/7109052)
ORCID
36.93 29
46 Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligo… (10.4061/2011/693761)
ORCID
36.93 29
47 Altered Dynamic Postural Control during Step Turning in Pers… (10.1155/2012/386962)
ORCID
36.56 28
48 Sleep Disturbances Associated with Parkinson's Disease (10.4061/2011/219056)
ORCID
36.56 28
49 Inflammatory Mechanisms of Neurodegeneration in Toxin-Based… (10.4061/2011/713517)
ORCID
36.56 28
50 Factors Influencing Quality of Life in Caregivers of People… (10.1155/2012/190901)
ORCID
36.18 27